Neurostimulation Devices | Market Insights | US | 2021
The US neurostimulation device market will grow rapidly, driven by expanding approval of these devices for new indications, increasing demand for non-pharmaceutical treatments, and the growing need for replacement devices as previously implanted devices begin to reach the ends of their life spans. Nevertheless, the COVID-19 pandemic will limit growth in the initial years of the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for neurostimulation devices in the US across a 10-year period.
